# Botulinum Toxin for Cramps in Diabetic Neuropathy

> **NCT03238898** · PHASE2 · COMPLETED · sponsor: **Presidio Ospedaliero Garibaldi-Centro** · enrollment: 50 (actual)

## Conditions studied

- Muscle Cramps Aggravated
- Diabetes Mellitus

## Interventions

- **DRUG:** Botulinum toxin type A
- **OTHER:** Normal saline

## Key facts

- **NCT ID:** NCT03238898
- **Lead sponsor:** Presidio Ospedaliero Garibaldi-Centro
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09-27
- **Primary completion:** 2017-05-03
- **Final completion:** 2017-05-03
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2017-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03238898

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03238898, "Botulinum Toxin for Cramps in Diabetic Neuropathy". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03238898. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*